These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 16 through Dec. 22, 2021. Source: InsiderScore.com
Activist Holdings
Harley-Davidson (HOG)
H Partners increased its position in the maker of iconic motorcycles to 12.3 million shares, equal to 8% of the outstanding stock. That figure accounts for the purchase of 740,000 Harley-Davidson shares priced at $35.82 to $37.73 each from Oct. 18 through Nov. 30. H Partners disclosed that while it is “supportive of [Harley-Davidson’s] management and strategic direction,” it has issues with the company’s corporate governance and executive compensation. H Partners has proposed adding a representative to Harley-Davidson’s board “to address these concerns” and align the motorcycle maker “with the best interests of shareholders.”
Increases in Holdings
Dave & Buster’s Entertainment (PLAY)
Hill Path Capital raised its interest in the casual-entertainment chain to 10.4%. Hill Path purchased a total of 258,863 Dave & Buster’s shares from Dec. 10 through Dec. 14 at prices ranging from $34.51 to $36.71 apiece. Following the fresh investment, Hill Path owns 5,018,004 Dave & Buster’s shares.
Purple Innovation
(PRPL)
Coliseum Capital Management raised its stake in the mattress and bedding maker to 13,019,027 Class A shares. Coliseum Capital bought a combined 4,780,115 Purple A shares on Dec. 16 and Dec. 17 at prices ranging from $10.13 to $11.38 apiece. After those buys, Coliseum Capital now holds a 19.6% interest in Purple’s A shares. Including Purple’s outstanding B shares, which don’t trade publicly, Coliseum’s interest is slightly reduced to 19.5%. Purple stock slid ahead of Coliseum’s share purchase after the company announced a CEO change, and said its outlook for calendar 2021 would be at the low end of prior guidance.
Decreases in Holdings
Advanced Drainage Systems (WMS)
Berkshire Partners Holdings reduced its position in the drainage systems company to 6,493,367 shares. On Dec. 14, Berkshire Partners sold 750,000 Advanced Drainage shares through a block-trade transaction that priced those shares at $125.25 each. No reason was given for the sale that leaves Berkshire Partners with a 9.1% interest in Advanced Drainage’s tradable stock.
Janux Therapeutics (JANX)
OrbiMed Advisors cut its holding in the cancer-focused biopharmaceutical firm to 3,018,386 shares. That figure includes 368,922 Janux shares held by British investment trust The Biotech Growth Trust, of which OrbiMed acts as the investment adviser. On Dec. 16, OrbiMed sold 448,000 Janux Therapeutics shares through a block-trade transaction at $19.07 each. OrbiMed now has an approximate 7.3% interest in Janux.
Email: [email protected]
